Warning: foreach() argument must be of type array|object, bool given in /var/www/html/web/app/themes/studypress-core-theme/template-parts/header/mobile-offcanvas.php on line 20

Private companies are now offering personal DNA sequencing along with interpretation. What services do they offer? Do you think that these services should be regulated, and if so, in what way?

Short Answer

Expert verified
Answer: Yes, personal DNA sequencing services should be regulated to address privacy, accuracy, and ethical concerns. Possible ways of regulation include establishing strict privacy regulations, setting standards for testing and interpretation methodologies, regulating advertising and marketing claims, and implementing anti-discrimination laws to prevent unfair use of genetic information. It is essential to regularly review and revise these regulations to keep up with the rapidly evolving field of personal genomics.

Step by step solution

01

Understand the services

Personal DNA sequencing services offered by private companies involve analyzing an individual's genetic code. They typically require the person to provide a DNA sample, usually through a simple saliva test, which is then sent to a lab for analysis. The services offered may include insights on ancestry, health predispositions, carrier status for genetic conditions, and traits linked to physical appearance, taste preferences, and sleep patterns. #Step 2: Consider the Benefits of These Services#
02

List benefits

These services offer numerous benefits to individuals. They can learn more about their genetic makeup, which can provide information about their ancestry and ethnicity. This can satisfy curiosity, offer insights into family history, or even reveal unknown relatives. Additionally, learning about their predispositions to certain health conditions can help individuals make proactive choices about their lifestyles and medical care, allowing them to take preventive measures. #Step 3: Identify Potential Concerns and Risks#
03

Address concerns

There are also potential concerns and risks associated with these services. Privacy is a major concern, as sensitive genetic information might be shared with or accessed by third parties without proper consent. Additionally, results may not always be accurate or may be interpreted differently by different providers, which can cause confusion or anxiety for individuals. There is also potential for genetic discrimination by insurance companies and employers if they access this information. #Step 4: Analyze Whether These Services Should Be Regulated#
04

Discuss regulation

Given the benefits and potential risks, it is important to consider whether authorities should regulate these services. Regulation can protect consumers' privacy, ensure improved accuracy of tests, and prevent unethical use of genetic information. While regulation can help address these concerns, it is important to strike a balance between safeguarding individual rights and allowing innovation and competition in this growing industry. #Step 5: Suggest Possible Ways of Regulation#
05

Propose ideas

If regulating these services, the following measures could be considered: 1. Establishing strict privacy regulations to protect consumers' genetic information from being shared or accessed without their consent 2. Ensuring accuracy in DNA testing and interpretation services by setting standards and guidelines for the methodologies used 3. Regulating advertising and marketing claims made by these companies, to prevent misleading or exaggerated claims 4. Implementing anti-discrimination laws to prevent employers or insurance companies from using genetic information against individuals It is essential to regularly review and revise these regulations to keep up with the rapidly evolving field of personal genomics.

Unlock Step-by-Step Solutions & Ace Your Exams!

  • Full Textbook Solutions

    Get detailed explanations and key concepts

  • Unlimited Al creation

    Al flashcards, explanations, exams and more...

  • Ads-free access

    To over 500 millions flashcards

  • Money-back guarantee

    We refund you if you fail your exam.

Over 30 million students worldwide already upgrade their learning with Vaia!

One App. One Place for Learning.

All the tools & learning materials you need for study success - in one app.

Get started for free

Most popular questions from this chapter

(a) Would you agree with Judge Sweet's ruling to invalidate the patenting of the \(B R C A 1\) and \(B R C A 2\) genes? If you were asked to judge the patenting of the direct-to-consumer test for the \(B R C A 1\) and \(B R C A 2\) genes, how would you rule? (b) \(\mathrm{J}\). Craig Venter has filed a patent application for his "firstever human made life form." This patent is designed to cover the genome of \(M .\) genitalium. Would your ruling for Venter's "organism" be different from Judge Sweet's ruling on patenting of the \(B R C A 1\) and \(B R C A 2\) genes?

What is the main purpose of genome-wide association studies (GWAS)? How can information from GWAS be used to inform scientists and physicians about genetic diseases?

There are more than 1000 cloned farm animals in the United States. In the near future, milk from cloned cows and their offspring (born naturally) may be available in supermarkets. These cloned animals have not been transgenically modified, and they are no different than identical twins. Should milk from such animals and their natural-born offspring be labeled as coming from cloned cows or their descendants? Why?

The first attempts at gene therapy began in 1990 with the treatment of a young girl with a genetic disorder abbreviated SCID. What does SCID stand for? In the context of SCID, what does ADA stand for?

Dominant mutations can be categorized according to whether they increase or decrease the overall activity of a gene or gene product. Although a loss-of- function mutation (a mutation that inactivates the gene product) is usually recessive, for some genes, one dose of the normal gene product, encoded by the normal allele, is not sufficient to produce a normal phenotype. In this case, a loss-of-function mutation in the gene will be dominant, and the gene is said to be haploinsufficient. A second category of dominant mutation is the gain- of-function mutation, which results in a new activity or increased activity or expression of a gene or gene product. The gene therapy technique currently used in clinical trials involves the "addition" to somatic cells of a normal copy of a gene. In other words, a normal copy of the gene is inserted into the genome of the mutant somatic cell, but the mutated copy of the gene is not removed or replaced. Will this strategy work for either of the two aforementioned types of dominant mutations?

See all solutions

Recommended explanations on Biology Textbooks

View all explanations

What do you think about this solution?

We value your feedback to improve our textbook solutions.

Study anywhere. Anytime. Across all devices.

Sign-up for free